Rochester Drug Cooperative

The firm was counsel to the official committee of unsecured creditors, and is currently representing the liquidation trustee, of drug distributor Rochester Drug Co-Operative. The debtor filed for bankruptcy protection in March 2020 after it was unable to pay money owed to the United States Department of Justice pursuant to a deferred prosecution agreement. The committee negotiated a liquidating plan that gave control of substantially all of the debtor’s assets to a liquidation trust. The liquidation trust has recovered funds through A/R collection, asset sales, and litigation. It also commenced an action alleging breaches of fiduciary duties against certain former directors and an officer of the company.

Our website uses cookies to enhance site navigation, analyze site usage, and assist in our marketing efforts. By continuing to browse this website, you agree to our Privacy Policy.